Profile: Shire Specialty Pharmaceuticals is a global specialty pharmaceutical company. We focus on developing projects and marketing products in the areas of the central nervous system, gastrointestinal & renal diseases. Agrylin is indicated for the treatment of essential thrombocythaemia, secondary to a myeloproliferative disorder. Dynepo is indicated for the treatment of anaemia in patients with chronic renal failure.
3 Products/Services (Click for related suppliers)
|• Pharmaceutical Market Research|